Literature DB >> 25168624

Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.

C Bruni1, F Conte, F Papa, C Sinisgalli.   

Abstract

This work concerns the optimization of the dose fractionation for cancer radiotherapy schedules of the kind one fraction/day, five fractions/week, assuming a fixed overall treatment time. Constraints are set to limit the radiation damages to surrounding normal tissues, as well as the daily fraction size. The response to radiation of tumour and normal tissues is represented by the classical LQ model, including the exponential repopulation term. We provide a framework to analytically determine the optimal weekly scheme of radiation doses as a function of the tumour type, the fraction upper bound and the normal tissue parameters. For a comparison with the literature, we present some numerical examples of optimal treatment schedules for specific tumour types.

Entities:  

Mesh:

Year:  2014        PMID: 25168624     DOI: 10.1007/s00285-014-0805-8

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  40 in total

1.  Optimal solution for a cancer radiotherapy problem.

Authors:  A Bertuzzi; C Bruni; F Papa; C Sinisgalli
Journal:  J Math Biol       Date:  2013-01       Impact factor: 2.259

2.  Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation.

Authors:  Melvin Astrahan
Journal:  Med Phys       Date:  2008-09       Impact factor: 4.071

Review 3.  Dose-rate effects in external beam radiotherapy redux.

Authors:  C Clifton Ling; Leo E Gerweck; Marco Zaider; Ellen Yorke
Journal:  Radiother Oncol       Date:  2010-04-01       Impact factor: 6.280

4.  Fractionation and protraction for radiotherapy of prostate carcinoma.

Authors:  D J Brenner; E J Hall
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-03-15       Impact factor: 7.038

Review 5.  Is there an optimum overall time for head and neck radiotherapy? A review, with new modelling.

Authors:  J F Fowler
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-02       Impact factor: 4.126

6.  Estimation of radiobiologic parameters and equivalent radiation dose of cytotoxic chemotherapy in malignant glioma.

Authors:  Bleddyn Jones; Paul Sanghera
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-26       Impact factor: 7.038

7.  Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1).

Authors:  Gabriella Macchia; Gabriella Ferrandina; Francesco Deodato; Valeria Ruggieri; Mariangela Massaccesi; Vanda Salutari; Vincenzo Valentini; Numa Cellini; Giovanni Scambia; Alessio G Morganti
Journal:  Gynecol Oncol       Date:  2010-05-21       Impact factor: 5.482

8.  Optimum overall times II: Extended modelling for head and neck radiotherapy.

Authors:  J F Fowler
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-12-26       Impact factor: 4.126

9.  Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3.

Authors:  C I Tang; D A Loblaw; P Cheung; L Holden; G Morton; P S Basran; R Tirona; M Cardoso; G Pang; S Gardner; A Cesta
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-10-05       Impact factor: 4.126

10.  What hypofractionated protocols should be tested for prostate cancer?

Authors:  Jack F Fowler; Mark A Ritter; Rick J Chappell; David J Brenner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

View more
  1 in total

1.  Exposure-response modeling improves selection of radiation and radiosensitizer combinations.

Authors:  Tim Cardilin; Joachim Almquist; Mats Jirstrand; Astrid Zimmermann; Floriane Lignet; Samer El Bawab; Johan Gabrielsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-10-08       Impact factor: 2.745

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.